175 related articles for article (PubMed ID: 9134274)
41. Differential effects of ACE-inhibition and angiotensin II antagonism on fibrinolysis and insulin sensitivity in hypertensive postmenopausal women.
Fogari R; Zoppi A; Preti P; Fogari E; Malamani G; Mugellini A
Am J Hypertens; 2001 Sep; 14(9 Pt 1):921-6. PubMed ID: 11587159
[TBL] [Abstract][Full Text] [Related]
42. Progressive intermittent claudication is associated with impaired fibrinolysis.
Killewich LA; Gardner AW; Macko RF; Hanna DJ; Goldberg AP; Cox DK; Flinn WR
J Vasc Surg; 1998 Apr; 27(4):645-50. PubMed ID: 9576077
[TBL] [Abstract][Full Text] [Related]
43. Effect of imidapril in dipper and nondipper hypertensive patients: comparison between morning and evening administration.
Kohno I; Ijiri H; Takusagawa M; Yin DF; Sano S; Ishihara T; Sawanobori T; Komori S; Tamura K
Chronobiol Int; 2000 Mar; 17(2):209-19. PubMed ID: 10757465
[TBL] [Abstract][Full Text] [Related]
44. A randomized, double-blind, parallel-group study to compare the anti-hypertensive effects of imidapril and nifedipine in the treatment of mild-to-moderate essential hypertension.
van der Does R; Euler R
J Int Med Res; 2001; 29(3):154-62. PubMed ID: 11471852
[TBL] [Abstract][Full Text] [Related]
45. Single dose and steady state pharmacokinetics and pharmacodynamics of the ACE-inhibitor imidapril in hypertensive patients.
Harder S; Thürmann PA; Ungethüm W
Br J Clin Pharmacol; 1998 Apr; 45(4):377-80. PubMed ID: 9578185
[TBL] [Abstract][Full Text] [Related]
46. Questioning a class effect: does ACE inhibitor tissue penetration influence the degree of fibrinolytic balance alteration following an acute myocardial infarction?
Tsikouris JP; Suarez JA; Meyerrose GE; Ziska M; Fike D; Smith J
J Clin Pharmacol; 2004 Feb; 44(2):150-7. PubMed ID: 14747423
[TBL] [Abstract][Full Text] [Related]
47. Imidapril hydrochloride in essential hypertension: a double-blind comparative study using enalapril maleate as a control.
Saruta T; Omae T; Kuramochi M; Iimura O; Yoshinaga K; Abe K; Ishii M; Watanabe T; Takeda T; Ito K
J Hypertens Suppl; 1995 Sep; 13(3):523-30. PubMed ID: 8592249
[TBL] [Abstract][Full Text] [Related]
48. Effects of imidapril and captopril on streptozotocin-induced diabetic nephropathy in mice.
Katoh M; Ohmachi Y; Kurosawa Y; Yoneda H; Tanaka N; Narita H
Eur J Pharmacol; 2000 Jun; 398(3):381-7. PubMed ID: 10862828
[TBL] [Abstract][Full Text] [Related]
49. Pharmacokinetic and pharmacodynamic interaction trial after repeated oral doses of imidapril and digoxin in healthy volunteers.
Harder S; Thürmann PA
Br J Clin Pharmacol; 1997 May; 43(5):475-80. PubMed ID: 9159562
[TBL] [Abstract][Full Text] [Related]
50. Bradykinin stimulates the release of tissue plasminogen activator in human coronary circulation: effects of angiotensin-converting enzyme inhibitors.
Minai K; Matsumoto T; Horie H; Ohira N; Takashima H; Yokohama H; Kinoshita M
J Am Coll Cardiol; 2001 May; 37(6):1565-70. PubMed ID: 11345366
[TBL] [Abstract][Full Text] [Related]
51. Tissue Angiotensin-converting enzyme activity plays an important role in pressure overload-induced cardiac fibrosis in rats.
Kurosawa Y; Katoh M; Doi H; Narita H
J Cardiovasc Pharmacol; 2002 Apr; 39(4):600-9. PubMed ID: 11904534
[TBL] [Abstract][Full Text] [Related]
52. Cough-challenge trial with a new angiotensin-converting enzyme inhibitor, imidapril.
Shionoiri H; Takasaki I; Minamisawa K; Ueda S; Kihara M; Shindo K; Hiroto S; Sugimoto K; Himeno H; Naruse M; Nagamochi I; Yasuda G
J Clin Pharmacol; 1998 May; 38(5):442-6. PubMed ID: 9602958
[TBL] [Abstract][Full Text] [Related]
53. Comparative effects of estrogen and angiotensin-converting enzyme inhibition on plasminogen activator inhibitor-1 in healthy postmenopausal women.
Brown NJ; Abbas A; Byrne D; Schoenhard JA; Vaughan DE
Circulation; 2002 Jan; 105(3):304-9. PubMed ID: 11804984
[TBL] [Abstract][Full Text] [Related]
54. Alterations in the fibrinolytic system components during acute myocardial infarction.
Ioannidou-Papayannaki E; Lefkos N; Boudonas G; Efthimiadis A; Psirropoulos D; Vogas V; Papadopoulos I; Klonizakis I
Acta Cardiol; 2000 Aug; 55(4):247-53. PubMed ID: 11041123
[TBL] [Abstract][Full Text] [Related]
55. Endogenous NO regulates plasminogen activator inhibitor-1 during angiotensin-converting enzyme inhibition.
Brown NJ; Muldowney JA; Vaughan DE
Hypertension; 2006 Mar; 47(3):441-8. PubMed ID: 16432054
[TBL] [Abstract][Full Text] [Related]
56. Dehydroepiandrosterone reduces plasma plasminogen activator inhibitor type 1 and tissue plasminogen activator antigen in men.
Beer NA; Jakubowicz DJ; Matt DW; Beer RM; Nestler JE
Am J Med Sci; 1996 May; 311(5):205-10. PubMed ID: 8615394
[TBL] [Abstract][Full Text] [Related]
57. Angiotensin-converting enzyme inhibitors post-myocardial infarction.
Young JB
Cardiol Clin; 1995 Aug; 13(3):379-90. PubMed ID: 7585774
[TBL] [Abstract][Full Text] [Related]
58. Effect of imidapril on myocardial remodeling in L-NAME-induced hypertensive rats is associated with gene expression of NOS and ACE mRNA.
Kobayashi N; Hara K; Watanabe S; Higashi T; Matsuoka H
Am J Hypertens; 2000 Feb; 13(2):199-207. PubMed ID: 10701821
[TBL] [Abstract][Full Text] [Related]
59. Effects of nicorandil on endogenous fibrinolytic capacity in patients with coronary artery disease.
Sakamoto T; Kaikita K; Miyamoto S; Kojima S; Sugiyama S; Yoshimura M; Ogawa H
Circ J; 2004 Mar; 68(3):232-5. PubMed ID: 14993778
[TBL] [Abstract][Full Text] [Related]
60. Effect of isotretinoin on endogenous tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1) in humans.
Wallnöfer AE; van Griensven JM; Schoemaker HC; Cohen AF; Lambert W; Kluft C; Meijer P; Kooistra T
Thromb Haemost; 1993 Dec; 70(6):1005-8. PubMed ID: 8165591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
